Found: 5
Select item for more details and to access through your institution.
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study.
- Published in:
- Cancer Reports, 2021, v. 4, n. 4, p. 1, doi. 10.1002/cnr2.1367
- By:
- Publication type:
- Article
The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 1, p. 103, doi. 10.1007/s40268-020-00336-x
- By:
- Publication type:
- Article
Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 6, p. 785, doi. 10.1007/s00280-022-04433-3
- By:
- Publication type:
- Article
Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article